Foresee Pharmaceuticals Co., Ltd.
TWO: 6576.TWO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Taipei Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Benjamin Chien
- Employees
- 15
- Headquarters
- Taipei, Taiwan
- IPO year
- 2016
- Market cap
- NT$12.4B
- Website
- https://www.foreseepharma.com
Loading 6576…
Loading profile data…Frequently asked questions about 6576
What does Foresee Pharmaceuticals Co., Ltd. (6576.TWO) do?
Foresee Pharmaceuticals Co., Ltd., a clinical-stage pharmaceutical company, engages in the development and commercialization of drugs in the United States, China, and Europe. The company's stabilized injectable formulation pipeline includes FP-001, which completed Phase III clinical study for the treatment of advanced stage prostate cancer; FP-0...
Where does 6576.TWO trade?
Foresee Pharmaceuticals Co., Ltd. (6576.TWO) trades on the Taipei Exchange.
What sector is 6576.TWO in?
Foresee Pharmaceuticals Co., Ltd. (6576.TWO) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Foresee Pharmaceuticals Co., Ltd.?
Benjamin Chien is the chief executive officer of Foresee Pharmaceuticals Co., Ltd. (6576.TWO).
Where is Foresee Pharmaceuticals Co., Ltd. headquartered?
Foresee Pharmaceuticals Co., Ltd. is headquartered in Taiwan.
Does 6576.TWO pay a dividend?
Foresee Pharmaceuticals Co., Ltd. (6576.TWO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 6576.TWO go public?
Foresee Pharmaceuticals Co., Ltd. (6576.TWO) completed its initial public offering in 2016.